Myleran
Busulfan
Myleran is a Prescription medicine medicine
Main Indication
Treatment of chronic granulocytic leukaemia. It has been shown to be superior to splenic irradiation when judged by survival times, control of spleen size and maintenance of haemoglobin levels. Although not curative, busulfan reduces the total granulocyte mass, relieves disease symptoms and improves the clinical state of the patient. Busulfan is not useful once blast transformation has occurred.
Busulfan produces prolonged remission in polycythaemia vera. It is especially useful in cases 32 resistant to radiophosphorus ( P) and where there is marked thrombocytosis. Busulfan is useful in selected cases of essential thrombocythaemia and myelofibrosis.
Therapeutic Area
Immunosuppressants
Myleran is available in these strengths:
- Myleran 2mg Tablet 25s Pack
